Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Stalenhoef

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|February 19, 2019
All good things come in threesJ W H J Geerts, J E Stalenhoef, D J van Westerloo
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[Endogenous endophtalmitis in a patient withStaphylococcus aureusbacteraemia]J H van den Besselaar, J S Chua, R van der Pol, et al.
The Journal of Urology|June 5, 2019
Reply by AuthorsJ E Stalenhoef, C van Nieuwkoop, P H Menken, et al.
The Netherlands Journal of Medicine|September 29, 2017
First case of severe pneumonic tularemia in an immunocompetent patient in the NetherlandsK C E Sigaloff, P K Chung, J Koopmans, et al.
The Journal of Infection|June 5, 2026
Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infectionV A Janes, J E Stalenhoef, Bcl Van der Putten, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 27, 2007
The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitusJ E Stalenhoef, B Alisjahbana, E J Nelwan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 22, 2014
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infectionW E van der Starre, S M Zunder, A M Vollaard, et al.
BMJ Open|April 21, 2023
Safe shortening of antibiotic treatment duration for complicated <i>Staphylococcus aureus</i> bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatmentDtp Buis, C H van Werkhoven, M A van Agtmael, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|February 19, 2019
All good things come in threesJ W H J Geerts, J E Stalenhoef, D J van Westerloo
Nederlands Tijdschrift Voor Geneeskunde|July 2, 2020
[Endogenous endophtalmitis in a patient withStaphylococcus aureusbacteraemia]J H van den Besselaar, J S Chua, R van der Pol, et al.
The Journal of Urology|June 5, 2019
Reply by AuthorsJ E Stalenhoef, C van Nieuwkoop, P H Menken, et al.
The Netherlands Journal of Medicine|September 29, 2017
First case of severe pneumonic tularemia in an immunocompetent patient in the NetherlandsK C E Sigaloff, P K Chung, J Koopmans, et al.
The Journal of Infection|June 5, 2026
Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infectionV A Janes, J E Stalenhoef, Bcl Van der Putten, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 27, 2007
The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitusJ E Stalenhoef, B Alisjahbana, E J Nelwan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 22, 2014
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infectionW E van der Starre, S M Zunder, A M Vollaard, et al.
BMJ Open|April 21, 2023
Safe shortening of antibiotic treatment duration for complicated <i>Staphylococcus aureus</i> bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatmentDtp Buis, C H van Werkhoven, M A van Agtmael, et al.
Pageof 1